vaccine immune response
Scope
Date
~
-
Artificial intelligence
42Maru builds defense-specialized GenAI platform
42Maru, South Korea's generative AI and language AI startup said on Friday that it was selected as the lead organization for the Defense Technolog...
Sep 20, 2024 (Gmt+09:00)
-
Construction
Hyundai opens climate change response edu Center in Vietnam
South Korea's Hyundai Engineering Co. said on Thursday that it has established a climate change response education center in Thanh Hoa Province, Vie...
Sep 12, 2024 (Gmt+09:00)
-
Korean startups
Enormous market ahead for Hopae, S.Korean DID pioneer
To Hopae Inc., a digital identity solution-developing startup native to South Korea, its home market is small. After successfully accommodating more...
Aug 22, 2024 (Gmt+09:00)
-
Korean startups
Asan Nanum Foundation revamps fund management
The Asan Nanum Foundation, a nonprofit foundation set up in 2011 to commemorate the 10th anniversary of Hyundai founder Chung Ju-yung’s death,...
Aug 20, 2024 (Gmt+09:00)
-
Bio & Pharma
SK Bioscience sells stake in US vaccine developer Novavax
SK Bioscience Co., a drug-making arm of South Korea's No. 2 conglomerate SK Group, has sold a stake in Nasdaq-listed vaccine developer Novavax Inc. ...
Aug 16, 2024 (Gmt+09:00)
-
Banking & Finance
Shinhan Financial builds disaster response system
South Korea's Shinhan Financial Group announced on Sunday that it established a disaster response system to provide swift and substantial assistance...
Jul 15, 2024 (Gmt+09:00)
-
Automobiles
LG Elec selected as Volkswagen's top supplier
LG Electronics Inc. was named the top supplier by Germany's Volkswagen Group. According to industry sources on Thursday, LG Electronics received the...
Jul 04, 2024 (Gmt+09:00)
-
Mergers & Acquisitions
SK Bioscience to buy German vaccine maker IDT Biologika for $244 mn
South Korea’s vaccine developer SK Bioscience Co. will acquire a controlling stake in the world’s top 10 vaccine firm IDT Biologika GmbH...
Jun 27, 2024 (Gmt+09:00)
-
North Korea
North Korea Sent Excrement Balloons. South Korea’s Response: Blasting BTS Hits.
SEOUL—After enduring days of balloon bombardment from the Kim Jong Un regime, South Korea countered with an airwaves assault of it...
Jun 18, 2024 (Gmt+09:00)
-
Bio & Pharma
EuBiologics gets WHO certification for cholera vaccine facility
South Korea's EuBiologics Co. announced on Friday that the vaccine bulk production facility at its Chuncheon Plant No. 2 for the oral cholera vacc...
May 17, 2024 (Gmt+09:00)
-
Business & Politics
Korean government vows stern response to Tokyo’s pressure on Naver
The South Korean government said on Monday it will resolutely respond to any “unfair” measures by Tokyo against Naver Corp., which is re...
May 13, 2024 (Gmt+09:00)
-
ESG
POSCO Future M publishes responsible minerals report
South Korea's POSCO Future M Co. announced on Tuesday that it released a responsible minerals report detailing establishing a sustainable supply cha...
May 07, 2024 (Gmt+09:00)
-
Corporate governance
Hanwha Vision joins UNGC
South Korea's Hanwha Vision Co. announced on Monday that it joined the United Nations Global Compact (UNGC), an international initiative for corpora...
Apr 29, 2024 (Gmt+09:00)
-
Bio & Pharma
SK Bioscience exports Sky Cellflu to Thailand
South Korea's SK Bioscience Co. announced on Thursday that it has shipped about 440,000 doses (for single-dose administration) of its cell-cultured ...
Mar 21, 2024 (Gmt+09:00)
-
Korean chipmakers
SK Hynix to build US chip packaging plant in Indiana: FT
SK Hynix Inc., the world’s second-largest memory chip producer, is reported to have picked Indiana as the site for its advanced chip packaging...
Feb 01, 2024 (Gmt+09:00)
-
Artificial intelligence
LG gets global AI management system certification
LG Electronics Inc. announced on Monday that it has received the Artificial Intelligence Management System (ISO/IEC 42001) certification, an interna...
Jan 22, 2024 (Gmt+09:00)
-
Bio & Pharma
SK Bioscience start to deliver Novavax COVID-19 vaccine
South Korea's SK Bioscience Co. announced on Tuesday that it started to deliver the Novavax COVID-19 vaccine against XBB.1.5 variant.According to No...
Dec 12, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Bioscience applies Phase 3 trials in US for pneumococcal vaccine
South Korea's SK Bioscience Co. announced on Monday that it submitted the Investigational New Drug (IND) application for the Phase 3 clinical trial ...
Dec 11, 2023 (Gmt+09:00)
-
Bio & Pharma
Korea to invest $200 mn in new drugs, vaccines by 2028
South Korea’s health ministry will allocate 261.6 billion won ($200.2 million) for two funds over the next four years to boost private sector ...
Nov 24, 2023 (Gmt+09:00)
-
Bio & Pharma
GC Biopharma wins $10 mn order for flu vaccine in Thailand
South Korea's GC Biopharma Corp. announced on Thursday that its flu vaccine GC Flu secured a $10 million order in the upcoming bid by Thailand's Gov...
Nov 23, 2023 (Gmt+09:00)
-
Bio & Pharma
KAIST, IVI to collaborate on global vaccine research
The Korea Advanced Institute of Science & Technology (KAIST) announced on Thursday that it signed a memorandum of understanding (MOU) with the I...
Nov 23, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Bioscience to develop 2nd-generation Ebola vaccine
South Korea's SK Bioscience Co. announced on Wednesday that it signed a business agreement with the international non-profit research organization H...
Nov 22, 2023 (Gmt+09:00)
-
Artificial intelligence
SK C&C AI diagnostic service checks Doosan Enerbility’s plants
SK C&C, a systems integration affiliate of South Korea’s SK Group, on Thursday said it will provide diagnostic services based on generativ...
Oct 20, 2023 (Gmt+09:00)
-
Bio & Pharma
S.Korean vaccine developer Quratis eyes Iraqi market
South Korean vaccine developer Quratis Inc. on Wednesday announced its signing of a term sheet on the direction and major transaction terms of coope...
Oct 12, 2023 (Gmt+09:00)
-
Bio & Pharma
Hugel resubmits application to FDA for botulinum toxin product
South Korea's biopharmaceutical company Hugel Inc., announced on Friday that it has resubmitted applications to the US Food and Drug Administration ...
Sep 01, 2023 (Gmt+09:00)
-
Bio & Pharma
EuBiologics, GC Biopharma to jointly produce cholera vaccine
South Korea's EuBiologics Co., the world's leading cholera vaccine company, has signed a joint production agreement with GC Biopharma Corp. to produ...
Aug 25, 2023 (Gmt+09:00)
-
Bio & Pharma
POSCO Int'l marks 1st animal vaccine exports
POSCO International Corp., the general trading and energy exploration unit of South Korea's steel giant POSCO Holdings Inc., announced on Thursday t...
Aug 24, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Bioscience resumes output of flu vaccine after two years
SK Bioscience Co., the drug-making unit of South Korea’s SK Group, on Wednesday shipped SKYCellflu, its vaccine for the common flu, for the fi...
Aug 24, 2023 (Gmt+09:00)
-
Bio & Pharma
Hanmi Pharm to start global clinical trials for immune-oncology drug
South Korea's Hanmi Pharmaceutical Co. announced on Tuesday that it has received approval for the phase 1 clinical trial plan of the immune-oncology...
Aug 22, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Bioscience to export $51 bn flu vaccine to Thailand
SK Bioscience Co., the drug-making unit of South Korea’s SK Group, announced on Monday that it has signed a deal with Thailand's state-owned G...
Aug 21, 2023 (Gmt+09:00)
Latest News
- 1 Hyundai, Waymo forge multi-year, strategic partnership for self-driving vehicles
- 2 AI startup MarqVision raises $16.5 mn to close Series A
- 3 Taihan Cable wins $630 mn power grid project in Singapore
- 4 Korean startup scene is gloomy, say 2 out of 5 startup CEOs
- 5 MBK ups stakes for Korea Zinc to match buyback offer